{{Rsnum
|rsid=4293296
|Chromosome=14
|position=54390568
|Orientation=plus
|GMAF=0.2397
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.2 | 44.6 | 46.2
| HCB | 4.4 | 20.0 | 75.6
| JPT | 7.2 | 36.9 | 55.9
| YRI | 5.8 | 47.8 | 46.4
| ASW | 9.3 | 44.4 | 46.3
| CHB | 4.4 | 20.0 | 75.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 39.8 | 59.2
| LWK | 7.5 | 54.2 | 38.3
| MEX | 7.1 | 33.9 | 58.9
| MKK | 14.3 | 52.6 | 33.1
| TSI | 6.0 | 46.0 | 48.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=0.000003
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}